Robert D. Hamilton

University of Mississippi Cancer ClinicJackson, Mississippi - 39216 (601-984-5590) |
- CLINICAL TRIALS 4
- CONDITIONS5
- INTERVENTIONS11
- SINCE2007

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
August 2008 - August 2013

Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
May 2009 - July 2010

Bevacizumab Sorafenib and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
September 2007 - May 2012

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Lung Neoplasms
Carcinoma, Renal Cell
Kidney Neoplasms
Head and Neck Neoplasms
Carcinoma, Small Cell
Aflibercept
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Gemcitabine Hydrochloride
Pemetrexed Disodium
Temsirolimus
Sorafenib Tosylate
Topotecan Hydrochloride
Vinorelbine Ditartrate



